1. Introduction {#sec0001}
===============

In December 2019, a cluster of atypical cases of pneumonia was reported in Wuhan, China, which was later designated as Coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO) on 11 Feb 2020 ([@bib0002]). The causative virus, SARS-CoV-2, was identified as a novel strain of coronaviruses that shares 79% genetic similarity with SARS-CoV from the 2003 SARS outbreak ([@bib0002]). On 11 Mar 2020, the WHO declared the outbreak a global pandemic ([@bib0002]).

The rapidly evolving situation has drastically altered people\'s lives, as well as multiple aspects of the global, public, and private economy. Declines in tourism, aviation, agriculture, and the finance industry owing to the COVID-19 outbreak are reported as massive reductions in both supply and demand aspects of the economy were mandated by governments internationally ([@bib0036]). The uncertainties and fears associated with the virus outbreak, along with mass lockdowns and economic recession are predicted to lead to increases in suicide as well as mental disorders associated with suicide. For example, [@bib0030] have reported a projected increase in suicide from 418 to 2114 in Canadian suicide cases associated with joblessness. The foregoing result (i.e., rising trajectory of suicide) was also reported in the USA, Pakistan, India, France, Germany, and Italy ([@bib0027]; [@bib0048]). Separate lines of research have also reported an increase in psychological distress in the general population, persons with pre-existing mental disorders, as well as in healthcare workers ([@bib0016]; [@bib0047]; [@bib0052]). Taken together, there is an urgent call for more attention given to public mental health and policies to assist people through this challenging time.

The objective of this systematic review is to summarize extant literature that reported on the prevalence of symptoms of depression, anxiety, PTSD, and other forms of psychological distress in the general population during the COVID-19 pandemic. An additional objective was to identify factors that are associated with psychological distress.

2. Methods {#sec0002}
==========

Methods and results were formated based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines ([@bib0033]).

2.1. Search strategy {#sec0003}
--------------------

A systematic search following the PRISMA 2009 flow diagram ([Fig. 1](#fig0001){ref-type="fig"} ) was conducted on PubMed, Medline, Embase, Scopus, and Web of Science from inception to 17 May 2020. A manual search on Google Scholar was performed to identify additional relevant studies. The search terms that were used were: (COVID-19 OR SARS-CoV-2 OR Severe acute respiratory syndrome coronavirus 2 OR 2019nCoV OR HCoV-19) AND (Mental health OR Psychological health OR Depression OR Anxiety OR PTSD OR PTSS OR Post-traumatic stress disorder OR Post-traumatic stress symptoms) AND (General population OR general public OR Public OR community). An example of search procedure was included as a supplementary file.Fig. 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) study selection flow diagram. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig 1

2.2. Study selection and eligibility criteria {#sec0004}
---------------------------------------------

Titles and abstracts of each publication were screened for relevance. Full-text articles were accessed for eligibility after the initial screening. Studies were eligible for inclusion if they: 1) followed cross-sectional study design; 2) assessed the mental health status of the general population/public during the COVID-19 pandemic and its associated risk factors; 3) utilized standardized and validated scales for measurement. Studies were excluded if they: 1) were not written in English or Chinese; 2) focused on particular subgroups of the population (e.g., healthcare workers, college students, or pregnant women); 3) were not peer-reviewed; 4) did not have full-text availability.

2.3. Data extraction {#sec0005}
--------------------

A data extraction form was used to include relevant data: (1) Lead author and year of publication, (2) Country/region of the population studied, (3) Study design, (4) Sample size, (5) Sample characteristics, (6) Assessment tools, (7) Prevalence of symptoms of depression/anxiety/ PTSD/psychological distress/stress, (8) Associated risk factors.

*2.4 Quality appraisal*

The Newcastle-Ottawa Scale (NOS) adapted for cross-sectional studies was used for study quality appraisal, which was modified accordingly from the scale used in [@bib0009]. The scale consists of three dimensions: Selection, Comparability, and Outcome. There are seven categories in total, which assess the representativeness of the sample, sample size justification, comparability between respondents and non-respondents, ascertainments of exposure, comparability based on study design or analysis, assessment of the outcome, and appropriateness of statistical analysis. A list of specific questions was attached as a supplementary file. A total of nine stars can be awarded if the study meets certain criteria, with a maximum of four stars assigned for the selection dimension, a maximum of two stars assigned for the comparability dimension, and a maximum of three stars assigned for the outcome dimension.

3. Results {#sec0006}
==========

3.1. Search results {#sec0007}
-------------------

In total, 648 publications were identified. Of those, 264 were removed after initial screening due to duplication. 343 articles were excluded based on the screening of titles and abstracts. 41 full-text articles were assessed for eligibility. There were 12 articles excluded for studying specific subgroups of the population, five articles excluded for not having a standardized/ appropriate measure, three articles excluded for being review papers, and two articles excluded for being duplicates. Following the full-text screening, 19 studies met the inclusion criteria.

3.2. Study characteristics {#sec0008}
--------------------------

Study characteristics and primary study findings are summarized in [Table 1](#tbl0001){ref-type="table"} . The sample size of the 19 studies ranged from 263 to 52,730 participants, with a total of 93,569 participants. A majority of study participants were over 18 years old. Female participants (*n* = 60,006) made up 64.1% of the total sample. All studies followed a cross-sectional study design. The 19 studies were conducted in eight different countries, including China (*n* = 10), Spain (*n* = 2), Italy (*n* = 2), Iran (*n* = 1), the US (*n* = 1), Turkey (*n* = 1), Nepal (*n* = 1), and Denmark (*n* = 1). The primary outcomes chosen in the included studies varied across studies. Twelve studies included measures of depressive symptoms while eleven studies included measures of anxiety. Symptoms of PTSD/psychological impact of events were evaluated in four studies while three studies assessed psychological distress. It was additionally observed that four studies contained general measures of stress. Three studies did not explicitly report the overall prevalence rates of symptoms; notwithstanding the associated risk factors were identified and discussed.Table 1Summary of study sample characteristics, study design, assessment tools used, prevalence rates and associated risk factors.Table 1Lead Author /yearCountryStudy designSample size (*n*=)Sample CharacteristicsAssessment toolPrevalence n/total (%)Common associated risk factors[@bib0001]ChinaCross-sectional study1074Age range: 14--68 Mean age: 33.54±11.13 Sex(f/m):503/571BAI, BDI-IIAnxiety symptoms: 311/1074 (29%) Depressive symptoms: 398/1074 (37.1%)Chi-square test: Anxiety: Age group (21--30 years) Depression: Age group (21--30 years).[@bib0011]ChinaCross-sectional study4827Age range: 18--85 Mean age: 32.3 ± 10.0 Sex(f/m): 3267/1560GAD-7, WHO-5Anxiety symptoms: 1091/4827 (22.6%) Depressive symptoms: 2331/4827 (48.3%)Logistic regression analysis: Anxiety: Age group (31--40 years), lower education level (middle school degree), married, poor self-rated health, frequent social media exposure (SME). Depression: Age group (21--30 years and 31--40 years), lower education level (middle school degree), living in urban area, poor self-rated health.[@bib0014]SpainCross-sectional study3480Age range: 18--80 Mean age: 37.92 Sex(f/m): 2610/870GAD-2, PCL-C-2, PHQ-2Anxiety symptoms: 752/3480 (21.6%) Depressive symptoms: 651/3480 (18.7%) PTSD symptoms: 550/3480 (15.8%)Linear regression analysis: Anxiety: Loneliness, female, receiving too much information. Depression: Loneliness, student status. PTSD symptoms: Loneliness, female gender, having a partner.[@bib0020]ChinaCross-sectional study7236Age range: 6--80 Mean age: 35.3 ± 5.6 Sex(f/m): 3952/3284CES-D, GAD-7Anxiety symptoms: 2540/7236 (35.1%) Depressive symptoms: 1454/7236 (20.1%)Logistic regression analysis: Anxiety: Younger participants (\<35 years), time spent focusing on COVID-19 (≥3 h/day). Depression: Younger participants (\<35 years)[@bib0022]ChinaCross-sectional study1593Age range: ≥18 Mean age: 32.3 ± 9.8 Sex(f/m): 976/617SAS, SDSAnxiety symptoms: 132/1593 (8.3%) Depressive symptoms: 233/1593 (14.6%)Linear regression analysis: Anxiety: Female gender, younger age group (\<30 years), divorced/widowed, living in rural region, living in more affected area, poor self-perceived health, affected by quarantine, worried about being infected, property damage. Depression: Female gender, younger age group (\<30 years), divorced/widowed, single status, student status, living in more affected area, lower household income, poor self-perceived health, affected by quarantine, worried about being infected, property damage.[@bib0025]ChinaCross-sectional study285Age range: ≥18 Mean age: N/A Sex(f/m): 155/130PCL-5PTSD symptoms: 20/285 (7%)Hierarchical regression analysis: PTSD symptoms: Female gender, poor sleep quality, unable to fall asleep.[@bib0028]ItalyCross-sectional study2766Age range: 18--90 Mean age: 32.94±13.2 Sex(f/m): 1982/784DASS-21Anxiety symptoms: 516/2766 (18.7%) Depressive symptoms: 904/2766 (32.7%) Stress symptoms: 751/2766 (27.2%)Multivariate ordinal logistic regression analysis: Anxiety: Young age, female gender, having a family member infected with COVID-19, having a history of mental stress/medical problems. Depression: Lower education levels, female gender, unemployment, not having a child, having an acquaintance infected with COVID-19, having a history of mental stress/medical problems. Stress: Young age, female gender, having to go out to work, having an acquaintance infected with the virus, having a history of mental stress/medical problems.[@bib0031]ItalyCross-sectional study500Age range: 18--75 Mean age: N/A Sex(f/m): 298/202K10Symptoms of psychological distress: 190/500 (38%)Logistic regression analysis: Psychological distress: People with cyclothymic, depressive, anxious temperaments, insecure-anxious attachment dimension "Need for approval".[@bib0032]IranCross-sectional study10,754Age range: N/A Mean age: N/A Sex(f/m): 7073/3681DASS-21 (Anxiety subscale)Mild-to-severe anxiety symptoms: 5472/10,754 (50.9%) \*Mild-to-average:  3419/10,754 (31.8%) Severe-to-very severe: 2053/10,754 (19.1%)Inferential statistics analysis (ANOVA, Chi-squared test, independent *t*-test): Anxiety: Residing in more COVID-19 affected regions, female gender, younger age group (21--40 years), higher education, people who frequently followed COVID-related news, having family member infected by COVID-19.[@bib0037]USACross-sectional study501Age range: ≥18 Mean age: 32.44±11.94 Sex(f/m): 277/224PHQ-2Depressive symptoms: N/A \*Occurrences of depressive symptoms were stratified based on socio-demographic information.One-way ANOVA/Pearson correlation analysis: Depressive symptoms: Single status, lower education, lower household income, student status, perceived risk of unemployment, COVID-related news exposure, younger age, people with higher perceived vulnerability, people with less efficacy to protect themselves.[@bib0038]SpainCross-sectional study976Age range: 18--78 Mean age: N/A Sex(f/m): 792/184DASS-21Symptoms of depression/anxiety/stress: N/A \* Rates of depression, anxiety, stress symptoms were stratified based on sociodemographic information (e.g. sex, age, etc.).Descriptive analysis: Anxiety, depression, and stress: Younger individuals (18\~25 years old), people with chronic disease.[@bib0039]TurkeyCross-sectional study343Age range: ≥18 Mean age: 37.16±10.31 Sex(f/m): 169/174HADSAnxiety symptoms: 155/343 (45.1%) Depressive symptoms: 81/343 (23.6%)Linear regression analysis: Anxiety: Female gender, living in urban areas and having a history of previous psychiatric illness. Depression: Living in urban areas.[@bib0041]ChinaCross-sectional study52,730Age range: N/A Mean age: N/A Sex(f/m): 34,131/18,599CPDISymptoms of psychological distress: 18,155/52,730 (34.43%)Logistic regression analysis: Psychological distress: Female gender, age group (18\~30 or \>60 years), occupation (migrant workers), regional severity of the disease (middle region of China).[@bib0042]NepalCross-sectional study374Age range: N/A Mean age: N/A Sex(f/m):195/179CPSS-10Moderate to high stress symptoms: 307/374 (82%)Logistic regression analysis: Stress: Student status, age group (\<30 years).[@bib0044]DenmarkCross-sectional study2458Age range: N/A Mean age: 49.1 Sex(f/m): 1254/1204WHO-5Depressive symptoms: 624/2458 (25.4%)Two sample *t*-test/Pearson correlation analysis: Depression: Female gender, higher levels of self-perceived depression and anxiety.[@bib0051]ChinaCross-sectional study1210Age range: 12--59 Mean age: N/A Sex(f/m): 814/396IES-R, DASS-21Symptoms of psychological impact: 651/1210 (53.8%) Depressive symptoms: 200/1210 (16.5%) Anxiety symptoms: 348/1210 (28.8%) Stress symptoms: 98/1210 (8.1%)Linear regression analysis: Common risk factors for all symptoms: Female gender, student status, poor self-rated health, specific physical symptoms (e.g., myalgia, dizziness, coryza), dissatisfaction about the availability of COVID-19 related information. Anxiety: Contact history with COVID+ patients or objects.H. [@bib0053]ChinaCross-sectional study1599Age range: 18--84 Mean age: 33.9 ± 12.3 Sex(f/m): 1068/531K6Symptoms of psychological distress: N/ALinear regression analysis: Psychological distress: Younger age, unmarried, history of visiting Wuhan in the past month, perceived more impacts of the epidemic, epidemic related dreams, negative coping styles.[@bib0054]ChinaCross-sectional study600Age range: 18--72 Mean age: 34±12 Sex(f/m): 333/267SAS, SDSAnxiety symptoms: 38/600 (6.33%) Depressive symptoms: 103/600 (17.17%)Logistic regression analysis: Anxiety: Female gender, age group (≤40 years). Depression: Higher education level (master\'s degree or above) Occupation (professionals).[@bib0056]ChinaCross-sectional study263Age range: ≥18 Mean age: 37.7 ± 14.0 Sex(f/m): 157/106IESPsychological impact (IES≥26): 20/263 (7.6%)Linear regression analysis: Psychological impact: N/A \* Sex, age, BMI, and education are NOT significantly associated with IES-scores.

3.3. Quality appraisal {#sec0009}
----------------------

The result of the study quality appraisal is presented in [Table 2](#tbl0002){ref-type="table"} . The overall quality of the included studies is moderate, with total stars awarded varying from four to eight. There were two studies with four stars, two studies with five stars, seven studies with six stars, seven studies with seven stars, and one study with eight stars.Table 2Results of study quality appraisal of the included studies.Table 2StudyTotal scoreSelectionComparabilityOutcomeRepresentativeness of the sampleSample sizeNon-respondentsAscertainments of exposureBased on design and analysisAssessment of outcomeStatistical test[@bib0001]6\*\*\*\*\*\*[@bib0011]6\*\*\*\*\*\*[@bib0014]4\*\*\*\*Huang 20206\*\*\*\*\*\*[@bib0022]7\*\*\*\*\*\*\*[@bib0025]8\*\*\*\*\*\*\*\*[@bib0028]7\*\*\*\*\*\*\*[@bib0031]7\*\*\*\*\*\*\*[@bib0032]6\*\*\*\*\*\*[@bib0037]6\*\*\*\*\*\*Ozamiz-Etxebarria 20205\*\*\*\*\*[@bib0039]7\*\*\*\*\*\*\*[@bib0041]4\*\*\*\*[@bib0042]7\*\*\*\*\*\*\*[@bib0044]5\*\*\*\*\*[@bib0051]6\*\*\*\*\*\*[@bib0053]6\*\*\*\*\*\*[@bib0054]7\*\*\*\*\*\*\*Zhang 20207\*\*\*\*\*\*\*

3.4. Measurement tools {#sec0010}
----------------------

A variety of scales were used in the studies (*n* = 19) for assessing different adverse psychological outcomes. The Beck Depression Inventory-II (BDI-II), Patient Health Questionnaire-9/2 (PHQ-9/2), Self-rating Depression Scales (SDS), The World Health Organization-Five Well-Being Index (WHO-5), and Center for Epidemiologic Studies Depression Scale (CES-D) were used for measuring depressive symptoms. The Beck Anxiety Inventory (BAI), Generalized Anxiety Disorder 7/2-item (GAD-7/2), and Self-rating Anxiety Scale (SAS) were used to evaluate symptoms of anxiety. The Depression, Anxiety, and Stress Scale- 21 items (DASS-21) was used for the evaluation of depression, anxiety, and stress symptoms. The Hospital Anxiety and Depression Scale (HADS) was used for assessing anxiety and depressive symptoms. Psychological distress was measured by The Peritraumatic Distress Inventory (CPDI) and the Kessler Psychological Distress Scale (K6/10). Symptoms of PTSD were assessed by The Impact of Event Scale-(Revised) (IES(-R)), PTSD Checklist (PCL-(C)-2/5). Chinese Perceived Stress Scale (CPSS-10) was used in one study to evaluate symptoms of stress.

3.5. Symptoms of depression and associated risk factors {#sec0010a}
-------------------------------------------------------

Symptoms of depression were assessed in 12 out of the 19 studies ([@bib0001]; [@bib0011]; [@bib0014]; [@bib0019]; [@bib0022]; [@bib0028]; [@bib0037]; [@bib0038]; [@bib0039]; [@bib0044]; [@bib0051]; [@bib0054]). The prevalence of depressive symptoms ranged from 14.6% to 48.3%. Although the reported rates are higher than previously estimated one-year prevalence (3.6% and 7.2%) of depression among the population prior to the pandemic ([@bib0018]; [@bib0024]), it is important to note that presence of depressive symptoms does not reflect a clinical diagnosis of depression.

Many risk factors were identified to be associated with symptoms of depression amongst the COVID-19 pandemic. Females were reported as are generally more likely to develop depressive symptoms when compared to their male counterparts ([@bib0022]; [@bib0028]; [@bib0044]; [@bib0051]). Participants from the younger age group (≤40 years) presented with more depressive symptoms ([@bib0001]; [@bib0011]; [@bib0019]; [@bib0022]; [@bib0037]; [@bib0038];). Student status was also found to be a significant risk factor for developing more depressive symptoms as compared to other occupational statuses (i.e. employment or retirement) ([@bib0014]; [@bib0022]; [@bib0037]). Four studies also identified lower education levels as an associated factor with greater depressive symptoms ([@bib0011]; [@bib0028]; [@bib0037]; [@bib0051]). A single study by [@bib0054] reported that people with higher education and professional jobs exhibited more depressive symptoms in comparison to less educated individuals and those in service or enterprise industries.

Other predictive factors for symptoms of depression included living in urban areas, poor self-rated health, high loneliness, being divorced/widowed, being single, lower household income, quarantine status, worry about being infected, property damage, unemployment, not having a child, a past history of mental stress or medical problems, having an acquaintance infected with COVID-19, perceived risks of unemployment, exposure to COVID-19 related news, higher perceived vulnerability, lower self-efficacy to protect themselves, the presence of chronic diseases, and the presence of specific physical symptoms ([@bib0011]; [@bib0014]; [@bib0022]; [@bib0028]; [@bib0037]; [@bib0038]; [@bib0039]; [@bib0051]).

3.6. Symptoms of anxiety and associated risk factors {#sec0011}
----------------------------------------------------

Anxiety symptoms were assessed in 11 out of the 19 studies, with a noticeable variation in the prevalence of anxiety symptoms ranging from 6.33% to 50.9% ([@bib0001]; [@bib0011]; [@bib0014]; [@bib0019]; [@bib0022]; [@bib0028]; [@bib0032]; [@bib0038]; [@bib0039]; [@bib0051]; [@bib0054]).

Anxiety is often comorbid with depression ([@bib0006]). Some predictive factors for depressive symptoms also apply to symptoms of anxiety, including a younger age group (≤40 years), lower education levels, poor self-rated health, high loneliness, female gender, divorced/widowed status, quarantine status, worry about being infected, property damage, history of mental health issue/medical problems, presence of chronic illness, living in urban areas, and the presence of specific physical symptoms ([@bib0001]; [@bib0011]; [@bib0014]; [@bib0019]; [@bib0022]; [@bib0028];  [@bib0032]; [@bib0038]; [@bib0039]; [@bib0051]; [@bib0054]).

Additionally, social media exposure or frequent exposure to news/information concerning COVID-19 was positively associated with symptoms of anxiety ([@bib0011]; [@bib0032]). With respect to marital status, one study reported that married participants had higher levels of anxiety when compared to unmarried participants ([@bib0011]). On the other hand, [@bib0022] found that divorced/widowed participants developed more anxiety symptoms than single or married individuals. A prolonged period of quarantine was also correlated with higher risks of anxiety symptoms. Intuitively, contact history with COVID-positive patients or objects may lead to more anxiety symptoms, which is noted in one study ([@bib0032]).

3.7. Symptoms of PTSD/ psychological distress/stress and associated risk factors {#sec0012}
--------------------------------------------------------------------------------

With respect to PTSD symptoms, similar prevalence rates were reported by [@bib0056] and N. [@bib0025] at 7.6% and 7%, respectively. Despite using the same measurement scale as [@bib0056] (i.e., IES), [@bib0051] noted a remarkably different result, with 53.8% of the participants reporting moderate-to-severe psychological impact. González et al. ([@bib0014]) noted 15.8% of participants with PTSD symptoms. Three out of the four studies that measured the traumatic effects of COVID-19 reported that the female gender was more susceptible to develop symptoms of PTSD. In contrast, the research conducted by [@bib0056] found no significant difference in IES scores between females and males. Other risk factors included loneliness, individuals currently residing in Wuhan or those who have been to Wuhan in the past several weeks (the hardest-hit city in China), individuals with higher susceptibility to the virus, poor sleep quality, student status, poor self-rated health, and the presence of specific physical symptoms. Besides sex, [@bib0056] found that age, BMI, and education levels are also not correlated with IES-scores.

Non-specific psychological distress was also assessed in three studies. One study reported a prevalence rate of symptoms of psychological distress at 38% ([@bib0031]), while another study from [@bib0041] reported a prevalence of 34.43%. The study from [@bib0053] did not explicitly state the prevalence rates, but the associated risk factors for higher psychological distress symptoms were reported (i.e., younger age groups and female gender are more likely to develop psychological distress) ([@bib0041]; [@bib0053]). Other predictive factors included being migrant workers, profound regional severity of the outbreak, unmarried status, the history of visiting Wuhan in the past month, higher self-perceived impacts of the epidemic ([@bib0041]; [@bib0053]). Interestingly, researchers have identified personality traits to be predictive of psychological distresses. For example, persons with negative coping styles, cyclothymic, depressive, and anxious temperaments exhibit greater susceptibility to psychological outcomes ([@bib0053]; [@bib0031]).

The intensity of overall stress was evaluated and reported in four studies. The prevalence of overall stress was variably reported between 8.1% to over 81.9% ([@bib0051]; [@bib0042]; [@bib0028]). Females and the younger age group are often associated with higher stress levels as compared to males and the elderly. Other predictive factors of higher stress levels include student status, a higher number of lockdown days, unemployment, having to go out to work, having an acquaintance infected with the virus, presence of chronic illnesses, poor self-rated health, and presence of specific physical symptoms ( [@bib0051]; [@bib0042]; [@bib0028]).

3.8. A separate analysis of negative psychological outcomes {#sec0012b}
-----------------------------------------------------------

Out of the nineteen included studies, five studies appeared to be more representative of the general population based on the results of study quality appraisal ([Table 1](#tbl0001){ref-type="table"}). A separate analysis was conducted for a more generalizable conclusion. According to the results of these studies, the rates of negative psychological outcomes were moderate but higher than usual, with anxiety symptoms ranging from 6.33% to 18.7%, depressive symptoms ranging from 14.6% to 32.8%, stress symptoms being 27.2%, and symptoms of PTSD being approximately 7% ([@bib0022]; [@bib0025]; [@bib0028]; [@bib0054]; [@bib0056]). In these studies, female gender, younger age group (≤40 years), and student population were repetitively reported to exhibit more adverse psychiatric symptoms.

3.9. Protective factors against symptoms of mental disorders {#sec0013}
------------------------------------------------------------

In addition to associated risk factors, a few studies also identified factors that protect individuals against symptoms of psychological illnesses during the pandemic. Timely dissemination of updated and accurate COVID-19 related health information from authorities was found to be associated with lower levels of anxiety, stress, and depressive symptoms in the general public ([@bib0051]). Additionally, actively carrying out precautionary measures that lower the risk of infection, such as frequent handwashing, mask-wearing, and less contact with people also predicted lower psychological distress levels during the pandemic ([@bib0051]). Some personality traits were shown to correlate with positive psychological outcomes. Individuals with positive coping styles, secure and avoidant attachment styles usually presented fewer symptoms of anxiety and stress ([@bib0053]; [@bib0031]). ([@bib0056]) also found that participants with more social support and time to rest during the pandemic exhibited lower stress levels.

4. Discussion {#sec0014}
=============

Our review explored the mental health status of the general population and its predictive factors amid the COVID-19 pandemic. Generally, there is a higher prevalence of symptoms of adverse psychiatric outcomes among the public when compared to the prevalence before the pandemic ([@bib0018]; [@bib0024]). Variations in prevalence rates across studies were noticed, which could have resulted from various measurement scales, differential reporting patterns, and possibly international/cultural differences. For example, some studies reported any participants with scores above the cut-off point (mild-to-severe symptoms), while others only included participants with moderate-to-severe symptoms ([@bib0032]; [@bib0051]). Regional differences existed with respect to the general public\'s psychological health during a massive disease outbreak due to varying degrees of outbreak severity, national economy, government preparedness, availability of medical supplies/ facilities, and proper dissemination of COVID-related information. Additionally, the stage of the outbreak in each region also affected the psychological responses of the public. Symptoms of adverse psychological outcomes were more commonly seen at the beginning of the outbreak when individuals were challenged by mandatory quarantine, unexpected unemployment, and uncertainty associated with the outbreak ([@bib0017]). When evaluating the psychological impacts incurred by the coronavirus outbreak, the duration of psychiatric symptoms should also be taken into consideration since acute psychological responses to stressful or traumatic events are sometimes protective and of evolutionary importance ([@bib0055]; [@bib0003]; [@bib0012]). Being anxious and stressed about the outbreak mobilizes people and forces them to implement preventative measures to protect themselves. Follow-up studies after the pandemic may be needed to assess the long-term psychological impacts of the COVID-19 pandemic.

4.1. Populations with greater susceptibility {#sec0015}
--------------------------------------------

Several predictive factors were identified from the studies. For example, females tended to be more vulnerable to develop the symptoms of various forms of mental disorders during the pandemic, including depression, anxiety, PTSD, and stress, as reported in our included studies ([@bib0001]; [@bib0011]; [@bib0022]). Greater psychological distress arose in women partially because they represent a higher percentage of the workforce that may be negatively affected by COVID-19, such as retail, service industry, and healthcare. In addition to the disproportionate effects that disruption in the employment sector has had on women, several lines of research also indicate that women exhibit differential neurobiological responses when exposed to stressors, perhaps providing the basis for the overall higher rate of select mental disorders in women ([@bib0013]; [@bib0007]).

Individuals under 40 years old also exhibited more adverse psychological symptoms during the pandemic ([@bib0001]; [@bib0011]; [@bib0019]). This finding may in part be due to their caregiving role in families (i.e., especially women), who provide financial and emotional support to children or the elderly. Job loss and unpredictability caused by the COVID-19 pandemic among this age group could be particularly stressful. Also, a large proportion of individuals under 40 years old consists of students who may also experience more emotional distress due to school closures, cancelation of social events, lower study efficiency with remote online courses, and postponements of exams ([@bib0004]). This is consistent with our findings that student status was associated with higher levels of depressive symptoms and PTSD symptoms during the COVID-19 outbreak ([@bib0022]; [@bib0037], [@bib0051]; [@bib0042]).

People with chronic diseases and a history of medical/ psychiatric illnesses showed more symptoms of anxiety and stress ([@bib0028]; [@bib0038]; [@bib0039]). The anxiety and distress of chronic disease sufferers towards the coronavirus infection partly stem from their compromised immunity caused by pre-existing conditions, which renders them susceptible to the infection and a higher risk of mortality, such as those with systemic lupus erythematosus ([@bib0043]). Several reports also suggested that a substantially higher death rate was noted in patients with diabetes, hypertension and other coronary heart diseases, yet the exact causes remain unknown ([@bib0015]; [@bib0008]), leaving those with these common chronic conditions in fear and uncertainty. Additionally, another practical aspect of concern for patients with pre-existing conditions would be postponement and inaccessibility to medical services and treatment as a result of the COVID-19 pandemic. For example, as a rapidly growing number of COVID-19 patients were utilizing hospital and medical resources, primary, secondary, and tertiary prevention of other diseases may have unintentionally been affected. Individuals with a history of mental disorders or current diagnoses of psychiatric illnesses are also generally more sensitive to external stressors, such as social isolation associated with the pandemic ([@bib0017]).

4.2. COVID-19 related psychological stressors {#sec0016}
---------------------------------------------

Several studies identified frequent exposure to social media/news relating to COVID-19 as a cause of anxiety and stress symptoms ([@bib0011]; [@bib0032]). Frequent social media use exposes oneself to potential fake news/reports/disinformation and the possibility for amplified anxiety. With the unpredictable situation and a lot of unknowns about the novel coronavirus, misinformation and fake news are being easily spread via social media platforms ([@bib0010]), creating unnecessary fears and anxiety. Sadness and anxious feelings could also arise when constantly seeing members of the community suffering from the pandemic via social media platforms or news reports ([@bib0023]).

Reports also suggested that poor economic status, lower education level, and unemployment are significant risk factors for developing symptoms of mental disorders, especially depressive symptoms during the pandemic period ([@bib0011]; [@bib0022]; [@bib0028]; [@bib0037];). The coronavirus outbreak has led to strictly imposed stay-home-order and a decrease in demands for services and goods ([@bib0036]), which has adversely influenced local businesses and industries worldwide. Surges in unemployment rates were noted in many countries ([@bib0046]; [@bib0045]). A decrease in quality of life and uncertainty as a result of financial hardship can put individuals into greater risks for developing adverse psychological symptoms ([@bib0035]).

4.3. Efforts to reduce symptoms of mental disorders {#sec0017}
---------------------------------------------------

### 4.3.1. Policymaking {#sec0018}

The associated risk and protective factors shed light on policy enactment in an attempt to relieve the psychological impacts of the COVID-19 pandemic on the general public. Firstly, more attention and assistance should be prioritized to the aforementioned vulnerable groups of the population, such as the female gender, people from age group ≤40, college students, and those suffering from chronic/psychiatric illnesses. Secondly, governments must ensure the proper and timely dissemination of COVID-19 related information. For example, validation of news/reports concerning the pandemic is essential to prevent panic from rumours and false information. Information about preventative measures should also be continuously updated by health authorities to reassure those who are afraid of being infected ([@bib0049]). Thirdly, easily accessible mental health services are critical during the period of prolonged quarantine, especially for those who are in urgent need of psychological support and individuals who reside in rural areas ([@bib0050]). Since in-person health services are limited and delayed as a result of COVID-19 pandemic, remote mental health services can be delivered in the form of online consultation and hotlines ([@bib0026]; [@bib0040]). Last but not least, monetary support (e.g. beneficial funds, wage subsidy) and new employment opportunities could be provided to people who are experiencing financial hardship or loss of jobs owing to the pandemic. Government intervention in the form of financial provisions, housing support, access to psychiatric first aid, and encouragement at the individual level of healthy lifestyle behavior has been shown effective in alleviating suicide cases associated with economic recession ([@bib0029]). For instance, declines in suicide incidence were observed to be associated with government expenses in Japan during the 2008 economic depression ([@bib0029]).

### 4.3.2. Individual efforts {#sec0019}

Individuals can also take initiatives to relieve their symptoms of psychological distress. For instance, exercising regularly and maintaining a healthy diet pattern have been demonstrated to effectively ease and prevent symptoms of depression or stress ([@bib0005]; [@bib0034]; [@bib0021]). With respect to pandemic-induced symptoms of anxiety, it is also recommended to distract oneself from checking COVID-19 related news to avoid potential false reports and contagious negativity. It is also essential to obtain COVID-19 related information from authorized news agencies and organizations and to seek medical advice only from properly trained healthcare professionals. Keeping in touch with friends and family by phone calls or video calls during quarantine can ease the distress from social isolation ([@bib0020]).

4.4. Strengths {#sec0020}
--------------

Our paper is the first systematic review that examines and summarizes existing literature with relevance to the psychological health of the general population during the COVID-19 outbreak and highlights important associated risk factors to provide suggestions for addressing the mental health crisis amid the global pandemic.

4.5. Limitations {#sec0021}
----------------

Certain limitations apply to this review. Firstly, the description of the study findings was qualitative and narrative. A more objective systematic review could not be conducted to examine the prevalence of each psychological outcome due to a high heterogeneity across studies in the assessment tools used and primary outcomes measured. Secondly, all included studies followed a cross-sectional study design and, as such, causal inferences could not be made. Additionally, all studies were conducted via online questionnaires independently by the study participants, which raises two concerns: 1\] Individual responses in self-assessment vary in objectivity when supervision from a professional psychiatrist/ interviewer is absent, 2\] People with poor internet accessibility were likely not included in the study, creating a selection bias in the population studied. Another concern is the over-representation of females in most studies. Selection bias and over-representation of particular groups indicate that most studies may not be representative of the true population. Importantly, studies in inclusion were conducted in a limited number of countries. Thus generalizations of mental health among the general population at a global level should be made cautiously.

5. Conclusion {#sec0022}
=============

This systematic review examined the psychological status of the general public during the COVID-19 pandemic and stressed the associated risk factors. A high prevalence of adverse psychiatric symptoms was reported in most studies. The COVID-19 pandemic represents an unprecedented threat to mental health in high, middle, and low-income countries. In addition to flattening the curve of viral transmission, priority needs to be given to the prevention of mental disorders (e.g. major depressive disorder, PTSD, as well as suicide). A combination of government policy that integrates viral risk mitigation with provisions to alleviate hazards to mental health is urgently needed.
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